What are the withdrawal symptoms of Prozac (fluoxetine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Withdrawal Symptoms of Prozac (Fluoxetine)

Prozac (fluoxetine) withdrawal symptoms typically include dysphoric mood, irritability, agitation, dizziness, sensory disturbances (such as electric shock sensations), anxiety, confusion, headache, lethargy, emotional lability, insomnia, and hypomania. 1

Common Withdrawal Symptoms

  • Dizziness and vertigo are among the most frequently reported symptoms when discontinuing Prozac 2
  • Sensory disturbances including paresthesias and "electric shock" sensations 1
  • Psychological symptoms including anxiety, irritability, confusion, and emotional lability 1
  • Sleep disturbances including insomnia and excessive dreaming 3
  • Headache, fatigue, and lethargy 2
  • Nausea, vomiting, and gastrointestinal disturbances 2
  • Flu-like symptoms 3

Timing and Duration of Symptoms

  • Withdrawal symptoms typically begin within 24-48 hours after discontinuation of the medication 3
  • Symptoms generally reach maximum intensity around day 5 3
  • Without intervention, symptoms may persist for 1-2 weeks, though in some cases they can last up to 3 weeks 3, 2
  • Prozac has a longer half-life compared to other SSRIs, which may result in less severe or less frequent withdrawal symptoms 4
  • If the medication is restarted, symptoms typically resolve within 72 hours 2

Risk Factors for Withdrawal

  • Abrupt discontinuation rather than gradual tapering significantly increases risk of withdrawal symptoms 1
  • Longer duration of treatment increases the risk of withdrawal symptoms 4
  • Higher dosages may lead to more severe withdrawal symptoms 3
  • Poor medication compliance (intermittent use) can trigger withdrawal symptoms 3
  • Concomitant medication use and alcohol consumption may worsen withdrawal 3

Severe Withdrawal Manifestations

  • While rare, delirium has been reported following abrupt discontinuation of fluoxetine 5
  • Hypomania may occur during withdrawal 1
  • In severe cases, withdrawal symptoms can significantly impair daily functioning 2

Prevention and Management

  • A gradual reduction in dose rather than abrupt cessation is strongly recommended 1
  • Tapering should ideally occur over a period of more than four weeks 6
  • If intolerable withdrawal symptoms occur during dose reduction, resuming the previously prescribed dose may be considered, followed by a more gradual taper 1
  • Patients should be monitored for withdrawal symptoms when discontinuing treatment 1
  • Patient education about potential withdrawal symptoms is important for prevention and management 3

Clinical Considerations

  • Withdrawal symptoms are often mistaken for relapse of the original condition, but withdrawal typically begins within days of discontinuation while true relapse usually takes longer to develop 2
  • The long elimination half-life of fluoxetine and its active metabolite (norfluoxetine) means that plasma concentrations decrease gradually at the conclusion of therapy, which may minimize the risk of discontinuation symptoms compared to other SSRIs 1, 4
  • Withdrawal symptoms from fluoxetine are generally less severe than those from shorter-acting SSRIs like paroxetine and fluvoxamine 4
  • Withdrawal symptoms should not be confused with serotonin syndrome, which is a different condition resulting from excessive serotonergic activity rather than decreased serotonin 7

References

Research

[Paroxetine withdrawal syndrome].

Annales de medecine interne, 2000

Research

Serotonin reuptake inhibitor withdrawal.

Journal of clinical psychopharmacology, 1996

Research

Delirium following abrupt discontinuation of fluoxetine.

Clinical neurology and neurosurgery, 2008

Research

Antidepressant Withdrawal and Rebound Phenomena.

Deutsches Arzteblatt international, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.